Laviv (autologous fibroblast cell therapy system) - Precigen, Paragon Biosci
Investor Presentation (Fibrocell Science) - Aug 10, 2012 - "Reports anecdotally suggest 75-82% of patients demonstrate treatment benefit 9 and 12 months following treatment" 
P2 data Fibrosis
http://www.larvolonline.com/tlg/ccdb/FibrocellScienceInvestorPresentationAug092012.pdf
 
Aug 10, 2012
 
(IR 7)
 
c287dc93-0aca-49db-afd8-c39580af35fb.jpg